Skip to main content

Table 3 Plasma phospholipid EPA, DHA, and total n-3 FA levels (mean ± standard deviation, AUC [%*h], cmax [%] and tmax [t]) 72 h after ingestion of supplements

From: Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil

   rTAG EE Krill oil p*
  EPA 37.05 ± 15.97 38.68 ± 18.60 53.62 ± 17.31 0.057
AUC [%*h] DHA 22.73 ± 26.23 8.85 ± 22.57 26.41 ± 29.54 0.246
  EPA+DHA 59.78 ± 36.75 47.53 ± 38.42 80.03 ± 34.71 0.119
  total n-3 FA 66.35 ± 37.53 49.49 ± 46.88 88.40 ± 42.81 0.134
  EPA 0.98 ± 0.26 0.79 ± 0.51 1.18 ± 0.45 0.095
cmax [%] DHA 0.42 ± 0.48 0.21 ± 0.18 0.40 ± 0.41 0.323
  EPA+DHA 1.12 ± 0.66 0.72 ± 0.76 1.51 ± 0.69 0.039
  total n-3 FA 1.44 ± 1.06 0.73 ± 0.76 1.44 ± 0.89 0.110
  EPA 11.5 ± 7.6 10.2 ± 8.6 7.8 ± 5.8 0.500
tmax [h] DHA 5.0 ± 6.2 9.8 ± 20.6 4.2 ± 6.6 0.538
  EPA+DHA 10.5 ± 10.2 9.0 ± 9.2 7.1 ± 6.0 0.649
  total n-3 FA 16.2 ± 20.2 9.0 ± 9.2 8.0 ± 8.2 0.307
  1. Abbreviations: rTAG: re-esterified triacylglycerides; EE: ethyl esters; AUC: area under the curve
  2. * ANOVA